ULBI

Ultralife Corporation (ULBI) 10Y Growth Potential Analysis (2026)

Invetso Score: 4.4/10 — Balanced · Last Updated: 2026-09-01

Monthly Update

No material changes this month.

Revenue Growth Drivers

Score: 4.8 (Moderate)

ULBI’s low-capex profile supports incremental capacity additions, but the absence of disclosed multi-year revenue CAGR limits evidence of durable compounding versus peers.

R&D intensity near 6% of revenue can support product refreshes, yet it is modest relative to peers with broader platforms and faster innovation cycles.

Negative net debt indicates balance-sheet flexibility for reinvestment, but weak interest coverage suggests financing capacity is not a clear growth advantage versus stronger peers.

Current valuation implies a small revenue base, which can aid percentage growth, but scale remains constrained without evidence of repeatable demand expansion.

Market Tailwinds

Score:

ULBI appears exposed to specialized battery and power solutions demand, but the filing evidence provided does not show a broad, durable end-market tailwind versus peers.

A concentrated industrial customer base can support recurring replacement demand, yet it typically grows slower than diversified peers with multiple secular demand vectors.

The company’s niche positioning may benefit from electrification-related spending, but no filing evidence here confirms sustained share gains or category expansion.

Compared with larger peers, ULBI’s market opportunity looks narrower, which limits long-term revenue acceleration even if demand remains stable.

Scalability Expansion

Score:

Capex at roughly 1.7% of revenue suggests asset-light scaling potential, but high cash-conversion-cycle days indicate working-capital drag versus more efficient peers.

The company’s reinvestment burden is manageable, yet low ROIC around 1.9% implies incremental capital has not translated into strong compounding capacity.

Limited disclosed segmentation data reduces evidence that ULBI can replicate growth across multiple products or geographies at peer-like scale.

Scalability appears adequate for steady expansion, but not strong enough to support top-tier long-term revenue compounding without clearer operating leverage.

Constraints Limitations

Score:

ROIC near 2% indicates weak capital productivity, which structurally limits the pace at which reinvested cash can compound revenue versus peers.

Interest coverage below 1.5x suggests limited financial flexibility, reducing the company’s ability to fund aggressive expansion through debt-supported growth.

A 160-day cash conversion cycle ties up working capital, which constrains self-funded scaling and makes growth more dependent on external liquidity.

The lack of disclosed multi-year growth history and segment breadth leaves limited evidence of repeatable, diversified expansion compared with stronger peers.

Overall Score

Score:

ULBI shows some capacity for incremental growth through modest reinvestment needs and balance-sheet flexibility, but weak capital productivity and working-capital intensity cap long-term compounding versus peers.

Score Driver: Weak Capital Productivity

Sources

  • Company filings (10-K, 10-Q, investor presentations)
  • Financial and market data providers
  • Public news and industry information

🔒 Go Beyond This Framework

This is one of 10 institutional-grade frameworks Invetso runs on Ultralife Corporation. Unlock the complete analysis — SWOT, Economic Moat, Porter’s Five Forces, Management, PESTLE and the Invetso Quality Score.

Create your free account on Invetso →